Urinary incontinence affects millions worldwide, but modern treatments now go far beyond adult diapers and pads. Experts say advanced therapies, minimally invasive procedures, and personalized care ...
The National Institute for Health and Care Excellence (NICE) has issued final draft guidance recommending vibegron (Obgemsa, Pierre Fabre) for treating overactive bladder (OAB) syndrome in adults. The ...
Overactive bladder (OAB) is typically not painful, but it can cause significant discomfort and a sudden, strong urge to urinate. OAB causes sudden, involuntary contractions of the bladder muscle, ...
Healthcare professionals may suggest bladder training and lifestyle approaches as the first-line treatment for older adults with overactive bladder (OAB). If symptoms persist, treatment may involve ...
Sumitomo Pharma's Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive bladder (OAB) symptoms receiving pharmacologic therapy for benign prostatic ...
By a News Reporter-Staff News Editor at Insurance Daily News-- Investigators discuss new findings in Managed Care. According to news reporting originating from Cleveland, Ohio, by NewsRx ...
An increase in overactive bladder (OAB) diagnoses was seen following publication of the first OAB guideline, and the rate of third-line therapy procedures also increased, according to a study ...
Christina Escobar, MD, MHPE, Assistant Professor in the Departments of Urology and Obstetrics and Gynecology at NYU Grossman School of Medicine, discusses, among other issues, how telehealth has ...
Zydus Lifesciences (ZYDUSLIFE) shares jumped after the Ahmedabad-headquartered pharmaceutical company launched Mirabegron ...
Waking up at night to use the bathroom? It might not be your water intake. Learn the real causes behind frequent nighttime ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results